Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-10)

Tables (1-2)

Sum=8

Nov 24, 2025 (publication date) through Nov 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Nov 24, 2025; 16(11): 111627
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111627

Table 1 The baseline characteristics of the training and validation sets, n (%)

ENTPD6: Ectonucleoside triphosphate diphosphohydrolase 6.

Table 2 The logistic regression results for the training set, mean ± SD/n (%)

^aP < 0.01.

^bP < 0.001.

¹Tumor vs normal.

ENTPD6: Ectonucleoside triphosphate diphosphohydrolase 6; OR: Odds ratio.

Citation: Wang G, Liu T, Zhang JX, Li YR, Zhu WJ, Wang JL, Dong WW, Zhang YY, Li YM, Yang LX, He LX, He WT. Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6. World J Clin Oncol 2025; 16(11): 111627
URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111627.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111627